|66.53||-0.3200||-0.48%||Vol 5.44M||1Y Perf 21.31%|
|Jun 4th, 2020 16:00 DELAYED|
|-0.34 -0.51%||- -%|
|Target Price||81.56||Analyst Rating||Moderate Buy 1.59|
|Potential %||22.59||Finscreener Ranking||★★+ 49.21|
|Insiders Trans % 3/6/12 mo.||-60/-71/-85||Value Ranking||★★ 47.85|
|Insiders Value % 3/6/12 mo.||-61/-98/-98||Growth Ranking||★★+ 49.24|
|Insiders Shares Cnt. % 3/6/12 mo.||-60/-97/-98||Income Ranking||★+ 40.32|
|Market Cap||86.96B||Earnings Rating||Sell|
|Price Range Ratio 52W %||57.98||Earnings Date||6th May 2020|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||1.63|
|EPS Growth Next 5 Years %||6.30|
|Avg. Weekly Volume||6.02M|
|Avg. Monthly Volume||7.24M|
|Avg. Quarterly Volume||10.32M|
CVS Health Corporation (NYSE: CVS) stock closed at 66.53 per share at the end of the most recent trading day (a -0.48% change compared to the prior day closing price) with a volume of 5.47M shares and market capitalization of 86.96B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 295000 people. CVS Health Corporation CEO is Larry J. Merlo.
The one-year performance of CVS Health Corporation stock is 21.31%, while year-to-date (YTD) performance is -10.45%. CVS stock has a five-year performance of -33%. Its 52-week range is between 52.04 and 77.03, which gives CVS stock a 52-week price range ratio of 57.98%
CVS Health Corporation currently has a PE ratio of 11.90, a price-to-book (PB) ratio of 1.32, a price-to-sale (PS) ratio of 0.33, a price to cashflow ratio of 6.00, a PEG ratio of 2.32, a ROA of 3.21%, a ROC of 6.02% and a ROE of 11.57%. The company’s profit margin is 2.75%, its EBITDA margin is 6.60%, and its revenue ttm is $262.26 Billion , which makes it $200.65 revenue per share.
Of the last four earnings reports from CVS Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.63 for the next earnings report. CVS Health Corporation’s next earnings report date is -.
The consensus rating of Wall Street analysts for CVS Health Corporation is Moderate Buy (1.59), with a target price of $81.56, which is +22.59% compared to the current price. The earnings rating for CVS Health Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
CVS Health Corporation has a dividend yield of 3.05% with a dividend per share of $2.00 and a payout ratio of 59.00%.
CVS Health Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 19.74, ATR14 : 1.73, CCI20 : 101.16, Chaikin Money Flow : 0.04, MACD : 1.37, Money Flow Index : 50.02, ROC : 4.59, RSI : 62.47, STOCH (14,3) : 80.07, STOCH RSI : 0.44, UO : 58.97, Williams %R : -19.93), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of CVS Health Corporation in the last 12-months were: Alan Lotvin (Buy at a value of $315 675), Eva C. Boratto (Option Excercise at a value of $965 399), Eva C. Boratto (Sold 16 260 shares of value $1 056 900 ), James D. Clark (Option Excercise at a value of $165 226), James D. Clark (Sold 9 534 shares of value $604 560 ), Jonathan C. Roberts (Option Excercise at a value of $3 754 063), Jonathan C. Roberts (Sold 57 563 shares of value $4 180 800 ), Jonathan E. Mayhew (Sold 10 556 shares of value $686 140 ), Joshua Flum (Option Excercise at a value of $1 930 689), Joshua Flum (Sold 35 406 shares of value $2 230 578 ), Karen S. Lynch (Sold 80 143 shares of value $6 010 725 ), Larry J. Merlo (Option Excercise at a value of $17 161 300), Larry J. Merlo (Sold 266 476 shares of value $19 929 740 ), Troyen A. Brennan (Option Excercise at a value of $1 287 126), Troyen A. Brennan (Sold 23 604 shares of value $1 605 072 )
Copyright (c) 2020. All rights reserved. Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.com, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.